New Delhi, September 12: Bharat Biotech said thar COVAXIN shows positive efficacy in animal trials and generated robust immune responses.
COVAXIN which has been developed jointly by the Indian Council of Medical Research and Bharat Biotech, is being tested at 12 institutes across India.
The results showed protective efficacy, increasing SARS-CoV-2 specific IgG and neutralizing antibodies, reducing replication of the virus in the nasal cavity, throat, and lung tissues of the monkeys.
|